Given that, the BoT-induced SNAP25 cleavage results in a secretory blockade, BoT-EGF could be beneficial not only for palliative care prior to surgery but also as a long-duration pharmacological intervention of non-malignant pheochromocytomas. This evidence concerns the gene EGF and malignant adrenal gland pheochromocytoma.